Why do teams with similar expertise achieve very different results?
I talk with coach and trainer Christina Sohn about how trust, shared goals, and constructive conflict shape team performance. We explore practical ways to speak up, handle disagreements, and strengthen collaboration in virtual teams.
Why do teams with similar expertise achieve very different results?
I talk with coach and trainer Christina Sohn about how trust, shared goals, and constructive conflict shape team performance. We explore practical ways to speak up, handle disagreements, and strengthen collaboration in virtual teams.
Why do teams with similar expertise achieve very different results?
I talk with coach and trainer Christina Sohn about how trust, shared goals, and constructive conflict shape team performance. We explore practical ways to speak up, handle disagreements, and strengthen collaboration in virtual teams.
When should we move beyond Excel for health technology assessment?
I sit down with Dr. Robert Smith to explore why increasingly complex health economic models call for a different approach—and how R can help.
We discuss the challenges of reviewing large spreadsheets, R’s strengths for simulation modelling, and how the R for HTA community shares tools and knowledge. Robert also explains how generative AI speeds up coding while making domain expertise, clear problem definition, and human judgement even more valuable. We close with practical ways to learn, contribute, and get involved in open-source work.
When should we move beyond Excel for health technology assessment?
I sit down with Dr. Robert Smith to explore why increasingly complex health economic models call for a different approach—and how R can help.
We discuss the challenges of reviewing large spreadsheets, R’s strengths for simulation modelling, and how the R for HTA community shares tools and knowledge. Robert also explains how generative AI speeds up coding while making domain expertise, clear problem definition, and human judgement even more valuable. We close with practical ways to learn, contribute, and get involved in open-source work.
When should we move beyond Excel for health technology assessment?
I sit down with Dr. Robert Smith to explore why increasingly complex health economic models call for a different approach—and how R can help.
We discuss the challenges of reviewing large spreadsheets, R’s strengths for simulation modelling, and how the R for HTA community shares tools and knowledge. Robert also explains how generative AI speeds up coding while making domain expertise, clear problem definition, and human judgement even more valuable. We close with practical ways to learn, contribute, and get involved in open-source work.
In this episode, I speak with Anna Mosikian, a physician by training and Global Clinical Program Lead working at the intersection of clinical development and strategic marketing.
Anna brings a powerful perspective on how clinical data translates into real-world value—bridging evidence generation, regulatory expectations, and commercial impact. We dive into what clinical leaders truly expect from statisticians and how statisticians can move from technical contributors to strategic partners.
We explore what “good collaboration” really looks like in practice, why understanding the purpose of a study is critical, and how statisticians can elevate their impact through communication, proactiveness, and cross-functional thinking.
In this episode, I speak with Anna Mosikian, a physician by training and Global Clinical Program Lead working at the intersection of clinical development and strategic marketing.
Anna brings a powerful perspective on how clinical data translates into real-world value—bridging evidence generation, regulatory expectations, and commercial impact. We dive into what clinical leaders truly expect from statisticians and how statisticians can move from technical contributors to strategic partners.
We explore what “good collaboration” really looks like in practice, why understanding the purpose of a study is critical, and how statisticians can elevate their impact through communication, proactiveness, and cross-functional thinking.
In this episode, I speak with Anna Mosikian, a physician by training and Global Clinical Program Lead working at the intersection of clinical development and strategic marketing.
Anna brings a powerful perspective on how clinical data translates into real-world value—bridging evidence generation, regulatory expectations, and commercial impact. We dive into what clinical leaders truly expect from statisticians and how statisticians can move from technical contributors to strategic partners.
We explore what “good collaboration” really looks like in practice, why understanding the purpose of a study is critical, and how statisticians can elevate their impact through communication, proactiveness, and cross-functional thinking.